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ABSTRACT
This document provides a technical position on the preferred level of 
isolation to fabricate demonstration quantities of mixed oxide transmutation 
fuels.  The Advanced Fuel Cycle Initiative should design and construct 
automated glovebox fabrication lines for this purpose.  This level of isolation 
adequately protects the health and safety of workers and the general public for all 
mixed oxide (and other transmutation fuel) manufacturing efforts while retaining 
flexibility, allowing parallel development and setup, and minimizing capital 
expense.
The basis regulations, issues, and advantages/disadvantages of five 
potential forms of isolation are summarized here as justification for selection of 
the preferred technical position.
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ACRONYMS
AFCF Advanced Fuel Cycle Facility
AFCI Advanced Fuel Cycle Initiative
LTA lead test assemblies
LWR light-water reactor
MOX mixed oxide (i.e. U + Pu)
QC quality control
SSNM strategic special nuclear material
1MOX Fabrication Isolation Considerations
INTRODUCTION
Mixed oxide (MOX) nuclear fuels containing Pu and Np, and potentially Am and/or Cm, need to 
be used for transmuting fission products and undesirable actinides in light-water reactors.  Initial 
manufacturing demonstrations for such fuels are expected to occur at an Advanced Fuel Cycle Facility 
(AFCF) currently being defined.
Questions have arisen over the type and complexity of isolation required for manufacture of these 
fuels.  Isolation is needed for the following:
x Prevent unacceptable worker exposure to ionizing radiation during manufacturing
x Prevent worker and/or public contamination from inadvertent release of actinides or fission 
products
x Ensure physical protection and control of the actinides being used in fabrication
x Provide resistance to proliferation of the actinide materials or fuel products.
Potential forms of isolation that may be considered would include the following, listed in order of 
increasing isolation and control:
1. Access controlled manual glovebox process lines
2. Access controlled manual shielded glovebox process lines
3. Access controlled automated glovebox process lines with area entry for maintenance/problem 
resolution
4. Manipulator controlled hot cell process lines
5. Automated hot cell process lines with manipulator controlled maintenance.
This document provides a technical position on the preferred level of isolation for an AFCF.  The 
basis regulations, issues, and advantages/disadvantages of the five potential forms of isolation will be 
summarized as justification for selection of the preferred technical position.
Summary Technical Position on 
Advanced Fuel Cycle Facility Approach
The Advanced Fuel Cycle Initiative (AFCI) program should design and construct demonstration 
facilities made to support an automated glovebox line fabrication approach.
This technical position is supported by the following:
1. Manual glovebox operations (even shielded gloveboxes) represent an unacceptable radiological 
hazard to operating personnel, and a single point failure would lead to worker and possibly public 
contamination.
22. The issue of criticality safety and the large number of batches involved with demonstration 
manufacturing make automation an attractive option that may be essential with some process 
operations.
3. An automated glovebox line can be placed and operated within an isolation room that provides 
both operator radiation protection and secondary contamination protection in the event of a 
glovebox leak.
4. Automated gloveboxes can be separately designed, constructed, and functionally tested in parallel 
with facility design and construction.  The proven glovebox units may then be placed and used in 
the facility as modules and removed as modules when the process demonstrations are complete.
Such modular designs would allow one facility to be used to demonstrate any number of different 
fuel processes.
POSITION ANALYSIS - BASIS DATA AND REQUIREMENTS
Demonstration Requirements
Transmutation fuels are currently being fabricated on a research scale in manual glovebox lines 
providing fuel for irradiation tests that quantify essential fuel performance parameters.  Manufacturing 
demonstrations will use the same or similar fabrication processes, but are inherently different than 
research scale fabrication in the following ways:
x A common source characteristic feed material is used that is representative of the feed material that 
will be used in production.
x Front end processes are used to condition the feed material for manufacture of the desired product
x Processing vessels are of a size and arrangement to adequately show how the process would be 
accomplished at production scale in a fuel manufacturing plant.
x Sequential unit process operations are performed in real time to develop process throughput and 
efficiency baselines.
x Nuclear material control and accounting, quality control sampling and testing, and quality 
assurance certification functions are performed the same way they would be performed for a 
production operation.
x Demonstration products are full lead test assemblies 4 to 12 feet long, ready for insertion in an 
operating test reactor or commercial light-water reactor (LWR).
Transmutation fuels contain fissionable actinide isotopes.  In basic LWR MOX compositions, the 
actinide quantities are low enough that options will exist for sizing demonstration equipment.  Inert 
matrix fuel MOX and the more advanced transmutation fuels will contain larger quantities of fissionable 
isotopes and process equipment sizes may be severely limited by criticality.  Demonstration process 
equipment should be as prototypic as possible within the limitations of the facility involved.  As a 
minimum, however, demonstration equipment must be designed to perform the process as it would be 
performed in a production environment.
3Fuel to be Demonstrated
Three potential MOX fuel variants may need to be demonstrated in the AFCF as listed in Table 1.
The MOX-1 composition is expected to be the first fuel demonstrated.  The MOX-2 fuel form is 
undesirable for fuel manufacture because of its additional radiological hazards, but represents the fuel 
form that would result from use of both the Pu/Np and Am/Cm products coming from separations.
MOX-3 is an estimated inert matrix composition range that would provide additional transmutation 
benefits by eliminating the uranium but is not yet ready to demonstrate.
Table 1. MOX Fuel Variants.
Compound MOX-1 MOX-2 MOX-3*
UO2 94.26% 93.5% 0
PuO2 5.30% 5.30% 14.0 – 20.0 %
NpO2 0.44% 0.44% 1.1 – 1.7 %
AmO2 0 0.69% 1.0 – 2.0 %
CmO2 0 0.07% 0
*An inert matrix MOX composition is provided for reference only as it would be the bounding case for the quantity of Pu that 
could potentially be placed in a MOX demonstration line.
Fuel Quantities Involved
Current estimates of the throughput required for fuel demonstrations are based on manufacture of 
two lead test assemblies for a LWR in a calendar year, assuming demonstration process operations are 
performed in three month runs, twice during the year.  With the following assumptions, an estimate of the 
required fuel throughput of a demonstration line (MOX-1 and MOX-2) was calculated using the mixed 
oxide process mass balancea.  The results are shown in Table 2.
Assumptions for Fuel Quantity Calculations
x Demonstrations will have unit process reject rates similar to those for development activities.  The 
process will not reach steady state in a three-month run so scrap recycle and recovery operations 
will not be factored into processing efficiencies, therefore, the total MOX process throughput 
efficiencyb will be approximately 73.3%.
x A Lead Test Assembly for a typical LWRc will be assumed to require 1.753 kg of fuel per fuel rod 
with 264 fuel rods per assembly.
a Mass balances for transmutation fuel processes were developed to allow analysis of manufacturing efficiencies based on an 
input composition that take into account process losses and gains from feed conditioning, fabrication, recycle, fuel recovery, and
quality control testing.
b As calculated using the Mixed Oxide Fuel Mass Balance developed for the AFCI Fuels program.
c These are generalized values for LWR MOX loading (assuming 85% dense pellets).
4Table 2.  MOX Fuel Quantities/Lead Test Assemblies (LTA).
Fuel Type Total Fuel 
Input/LTA
Total Actinide 
Input/LTA
U
Input
Pu
Input
Np
Input
Am
Input
Cm
Input
MOX-1 633.0 kg 558.01 kg 525.80 kg 29.77 kg 2.44 kg 0 0
MOX-2 633.0 kg 558.02 kg 521.50 kg 29.77 kg 2.44 kg 3.90 kg 0.40 kg
MOX-3 79 kg* 9 kg*
*Pu and Np quantities for a direct replacement inert matrix fuel MOX are estimates only.  A detailed mass balance is not yet 
available as the process is still being designed.
Batch Size Determination
The following assumptions are provided for determination of the demonstration batch size:
x Four days are required at the end of the fabrication campaign to assemble the lead test assembly
x An average timing of four hours/unit process for fabrication and quality control (QC) sequences 
should be sufficient
x Demonstration operations will be a seven day/week, eight hours/day batch processing operation
x Demonstration facilities will be sized to allow completion of one lead test assembly from an 
approximate three-month fabrication campaign.
A MOX fuel blending and processing line requires 21 unit processes.  QC performed for the 
process adds an additional 14 unit processes.  With the stated assumptions, each batch processing quantity 
will take an average of 18 daysd to move from initial blending to finished fuel.  Two batch quantities may 
enter the process line each day but the last two batches must enter by day 68 to be complete by the end of 
day 86 and allow assembly by day 90 of the campaign.  Therefore, the minimum batch size for 
demonstration would be:
633.0 kg oxide/(2 batches/day x 68 days ) = 4.66 kg/batch (minimum)
Preliminary criticality safety studies1 indicate that the above minimum batch size is reasonable for 
dry process operations.  If liquid compositional blending of fuel materials is determined necessary, 
smaller quantities would need to be processed in parallel and then combined after denitration to form the 
batch used for the remainder of fuel fabrication.
For simplicity of analysis, a nominal batch size of 5.0 kg will be used for all dose rate 
considerations in this document.
d Although some QC unit processes may be performed in parallel with production, the assumption is that acceptable QC results
will be needed before taking the batch through the following unit processes.
5Applicable Regulations and Requirements
Worker Radiological Exposure
Radiological exposure to workers is limited to the exposure limits in 10 CFR 835, summarized as 
follows:
1. Total effective annual dose of 5 rem/year (10 CFR 835.202.1)
2. Total dose to eyes of 15 rem/yr (10 CFR 835.202.2)
3. Total external dose to extremities, skin, or organs of 50 rem/yr (10 CFR 835.202.2 & 4)
4. Total dose to an unborn embryo/fetus 0.5 rem (10 CFR 835.206)
However, beyond the basic limits of the order, DOE applies several more restrictive limits for new 
facilities or modifications to existing facilities.  Paragraph 10 CFR 835.1002 requires design objectives 
for exposures less than “0.5 mrem/hr and as far below this average as reasonably achievable.”  It further 
requires that where these design objectives cannot be met, the limits shall not exceed 20% of the 
applicable limits itemized above.
Beyond the specific requirements in 10 CFR 835, DOE has issued DOE-STD-1098-99,
Radiological Control which adds a “recommended design criteria” limiting individual worker doses to a 
maximum of 0.25 mrem/hr or 500 mrem/yr. 
Site Boundary Release
The Site boundary air release of radionuclides is limited by 40 CFR 61.  The maximum allowable 
dose for a member of the general public at the site boundary is 10 mrem/year.
Physical Protection
As a fixed site, physical protection requirements applicable to the AFCF are specified in 
10 CFR 73.40, 45, and 46 as summarized belowe:
1. Provide methods to prevent unauthorized access of persons, vehicles, and materials
2. Provided methods to ensure only authorized activities and conditions within the protected area
3. Permit only authorized placement and movement of strategic special nuclear material (SSNM)
4. Control removal of only authorized and confirmed forms and amounts of SSNM
5. Provide for authorized access to assure detection of and response to unauthorized penetrations of 
the protected area
6. Provide response capability to assure compliance with other provisions.
e Although 10 CFR 73 is an NRC requirement, even if DOE elects not to have the facility licensed, it must be assumed that DOE 
would still require the facility to meet the intent of the NRC requirements.
6The key to successful design of physical protection for an AFCF will be in the definition of 
controlled and protected areas such that fabrication operations are not unnecessarily hindered, while 
physical protection requirements are fully met.
Material Control and Accounting/Proliferation Resistance
Formula quantities (quantities over 5 kg of Pu) of strategic special nuclear materials are controlled 
and accounted for using the requirements of 10 CFR 74 Subpart E, unless credit for Np, Am, or Cm 
additions will allow a downgrading of requirements.  Although an intrinsic improvement in proliferation 
resistance is obtained when the Pu is combined with other actinides, the way this would be handled in 
regulatory space has not been defined.
It is expected that regardless of actinide additions, a material control and accounting system will be 
required that achieves the following:
1. Prompt investigation of anomalies in SSNM inventories
2. Timely detection of the possible loss or diversion of SSNM
3. Rapid determination of whether a loss or diversion occurred
4. Ongoing confirmation of the presence of SSNM in assigned locations
5. Timely generation of information to aid in the recovery of SSNM in the event of an actual loss or 
diversion.
Criticality Safety
Criticality-safety-specific requirements are established in standard ANSI/ANS-8.1-1983 (R 1988),
which is endorsed by DOE and NRC.2  These requirements are supplemented and interpreted by DOE for 
National Laboratories where specific criticality safety programs are implemented.
General criticality safety criteria include:
x Systems must comply with DOE’s double contingency requirement if a criticality accident is 
credible.f,g
Unless specific criticality safety organization concurrence is obtained, systems must comply with a 
single failure limit (maximum 0.95 keff under single failure conditions) when safety margins are 
determined from analytic modeling.
f  In this context, a criticality accident is deemed credible if both (1) a sequence of events leading to a critical condition is
identified and (2) enveloping or specific, documented arguments do not demonstrate it is beyond extremely unlikely that the 
entire sequence could occur.
g  Currently, DOE’s double contingency requirement is different from the traditional double contingency principle.  National 
standards recommend application of the double contingency principle, which involves the use of controls on two independent 
parameters (for example, geometry and mass, or mass and moderator) such that each control failure is unlikely.  DOE’s double 
contingency requirement is more extensive because it requires the use of multiple controls on a single parameter if it is not 
practical to apply the traditional double contingency principle.
7The NRC fuel cycle staff instituted interim guidance, ISG-10, that essentially establishes 0.90 keff
as the upper safety limit for plutonium systems whose safety is evaluated with analytical modeling unless 
calculation validation and bias identification are sufficiently rigorous. Such a review practice might 
reduce the above-quoted 0.95 keff values for the AFCI if (1) DOE adopts similar guidance, and (2) DOE 
reviewers require the same calculation validation for calculations using Np, Am, and/or Cm cross section 
data as is required for calculations using Pu cross section data.h  However, such issues might be avoided if 
criticality safety limits are based solely on Pu and, if present, U, for which it appears sufficient benchmark 
data are available to use in validating calculation sensitivity and uncertainty. 
x If a system is to be considered critically safe by mass alone, the limit must be set at no more than 
75 percent of the critical mass, or, if over-batching is credible, no more than 45 percent of the
critical mass.i
Figure 1. Distances to fuel batches for radiological dose calculations.
Worker Radiological Dose Calculations
To evaluate possible modes of operation for a new AFCF, some estimate of radiological dose is 
needed.
The most desirable situation would be a stable, well-trained workforce that is able to work year-
around in the facility without radiological restrictions.  The requirements listed show that radiological 
fabrication should be designed to limit exposures to one-tenth or less of the DOE regulatory limits 
(500 mR whole body and 5 R extremity).  If no shielding is employed in the glovebox operation, the 
radiological dose that would be sustained by operators during glovebox operations can be calculated from
the fuel isotopic and elemental composition and distance from the source (assuming no significant 
shielding from the polycarbonate glovebox walls).  An estimated glovebox exposure situation (without 
shadow shielding) for a worker operating a unit process involving a 5 kg batch of fuel with other fuel 
batches in the unit processes 107 cm (42 in.) on either side is shown in Figure 1.  A dose rate study3
developed the calculation routines for analyzing dose rates from reprocessed LWR fuel using other AFCI 
fuel compositions.  The same calculation routines were used with the MOX 1 and 2 fuel compositions to 
h  Part of the problem is that, with the exception of one Np benchmark, no peer-reviewed benchmark data has been identified to 
date for Np, Am, and/or Cm.
i  In these cases minimum critical mass is determined with the system in its most reactive credible state.  Similar criteria are
applied for analogous controls, such as controls based on a minimum critical number of pieces.
8generate dose rate data specifically applicable to MOX fabrication (see Appendixes A and Bj) that is 
summarized in Figures 2 and 3.  Using the dose rate curves with exposures from three primary sources, 
and assuming that the operator is physically at this location for only four hours/day, the estimated 
accumulated dose for MOX 1 and 2 f fuel fabrication would be as shown in Table 3.
Figure 2.  MOX-2 Dose Rate.
Figure 3.  MOX-1 Dose Rate
j Calculations provided by Bradley J. Schrader.
9Table 3. Unshielded Glovebox Whole Body and Extremity Doses.
Fuel in 
Process
Whole Body 
Dose/day
Extremity
Dose/Day
Whole Body Dose/90 
days
Extremity Dose/90 
days
MOX – 1 28 mR 912 mR 2.5 R 82 R
MOX – 2 140 mR 2848 mR 12.6 R 256 R
Strategic placement of shadow shielding devices (typically lead or tungsten bricks) within the 
gloveboxes and use of tungsten impregnated glovebox walls would greatly reduce whole body exposures 
but may not be sufficient to affect a major reduction in extremity (hand) exposures.
Isolation Alternatives Evaluation
Manual Gloveboxes
Manually operated glovebox fabrication involves the isolation of materials and unit processes 
within atmosphere-controlled, remote boxes or lines that are typically held at a lower atmospheric 
pressure than the operating area external to the box.   Processes are performed manually by personnel 
working through glove ports strategically located along the sides of the box line.
Advantages
1. Manual gloveboxes allow direct operator control of processes and would be the closest to “hands-
on” fabrication
2. Operators have a direct view of what is being done which simplifies intricate tasks
3. Probably the least time and capital expense is involved with line design and setup
4. Gloveboxes may be designed and tested in parallel with facility design and construction.
Disadvantages
1. Operator radiation exposure may be reduced sufficiently using shadow shielding approaches to 
make manufacture of MOX-1 composition fuels feasible, but MOX-2 compositions probably could 
not be manufactured this way
2. Worker contamination is possible from a single point failure (gloves or glove port connections
3. Physical protection, nuclear material control, and criticality safety are more difficult to ensure 
because of the direct human involvement in the unit processes.
Manual Shielded Gloveboxes
Manually operated shielded glovebox fabrication is quite similar to the manual operation discussed 
above with the exception that the gloveboxes are radiation shielded.   Processes are still performed 
manually by personnel working through glove ports strategically located along the sides of the box line.
Shielded gloveboxes are helpful in reducing whole body radiation doses through incorporation of 
shielding in the construction of the glovebox.
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Advantages
1. Shielded manual gloveboxes still allow direct operator control of processes
2. Operators still have a direct view of what is being done although glovebox walls may be thicker 
and it may be more difficult to view what is being done through heavier shielded glass windows
3. Gloveboxes may be designed and tested in parallel with facility design and construction.
Disadvantages
1. Even well designed glovebox shielding approaches would not be expected to sufficiently protect 
the worker from extremity exposures, especially while fabricating MOX–2 fuel
2. Operator functions would be more difficult while working around the shielding
3. Worker contamination is possible from a single point failure (gloves or glove port connections
4. Physical protection, nuclear material control, and criticality safety are more difficult to ensure 
because of direct human involvement in the unit processes.
Automated Gloveboxes – Manual Maintenance
This would be a process line, designed to fit within a glovebox line, in which the unit processes and 
material transfers are automated and the operator directs the processing electronically from behind a 
radiation shield, shielding wall, or physical barrier.  The glove ports would be used only by maintenance 
personnel to repair or maintain the equipment.  If the glovebox line is placed in a sealed and shielded 
room, a second level of isolation and contamination control would be realized.
Advantages
1. Automation provides a major reduction in both whole body and extremity radiation dose to
operating personnel
2. Worker contamination from a failure of the glovebox containment is less likely because the 
operator is not immediately adjacent to the box and contamination may be detected and mitigated 
prior to personnel involvement
3. Physical protection, nuclear material control, and criticality safety are improved because material 
movements are automatically controlled (except during an equipment failure)
4. Overall fuel fabrication time will be minimized by automated material handling between process 
operations
5. Glovebox lines may be designed and tested in parallel with facility design and construction.
Disadvantages
1. Automating the unit processes within a glovebox environment would require more intricate process 
and equipment design and the inclusion of material handling robotics that would not be used in 
manual operations
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2. More time and expense is involved in the design and setup of an automated line
3. Automation involves electronics for robotics, sensors, cameras, etc. that are more prone to failure 
in a radiation environment
4. Although less probable, maintenance worker contamination from a single point failure (gloves or 
glove port connections) is still possible
5. Maintenance requirements for an automated process line may increase over those needed for a less-
complex manually operated line, leading to higher radiation exposures for maintenance personnel. 
(Especially if equipment failures occur that do not allow removal of the actinide materials before 
repairs are initiated.)
Manipulator Controlled Hot Cell Processing
Hot cell unit processes are performed within sealed and shielded cells operating at a lower pressure 
or inert gas atmosphere that protects operators from radiation.  Operator functions are done using hand-
operated manipulators that translate hand movements to the movement of manipulator end effectors 
within the cell.  The equipment used in hot cell operations is usually rebuilt to allow simplified remote 
manipulation using standard end effectors.
Advantages
1. Hot cells should nearly eliminate operator radiation exposure during normal operations.  Therefore, 
they could support extended fabrication campaigns, if required, without significant additional 
exposure to workers.
2. As fully sealed hard wall units, hot cells essentially preclude the possibility of worker 
contamination during normal operations.
3. Physical protection, and nuclear material control, are enhanced if the material balance areas can be 
designed to coincide with cell boundaries.  Configuration control can be rigidly maintained.
4. Although criticality events have about the same probability as in manual glovebox operations, the 
effects of a criticality event would be minimal and should be contained within the hot cell.
5. The potential for a release at the site boundary is reduced due to the additional hard wall 
containment boundary.
Disadvantages
1. Hot cells represent a major facility expense and have little flexibility.
2. The time required to design and construct a hot cell facility are much greater than for a glovebox 
facility.  Process setup and testing would need to be done after facility construction.
3. Hot cell manufacturing would be operationally much slower than glovebox lines due to the 
difficulty involved using manipulators.
4. Some maintenance operations may still require cell entry with corresponding radiation exposure 
and potential for worker contamination.
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Automated Hot Cell Processing - Manipulator Maintenance
Automated hot cell unit processes are performed within sealed and shielded cells operating at a 
lower pressure or inert gas atmosphere that protects operators from radiation.  Operator functions are done 
remotely at a control panel that monitors fabrication processes and material movements.  Hand-operated
manipulators would be used primarily by maintenance personnel to affect repairs and perform 
maintenance tasks.
Advantages
1. This approach to hot cell operation should nearly eliminate both operator and maintenance 
personnel radiation exposures during normal operations.  This capability would assist in preventing 
exposures for even very long process demonstrations or production operations.
2. As fully sealed hard wall units, hot cells essentially preclude the possibility of worker 
contamination during normal operations.
3. Both physical protection and nuclear material control should be optimum with this operational 
approach.  Automation of nuclear material control functions is possible.  Configuration control may 
be electronically inter-tied to the equipment operation.
4. Criticality safety is improved over manual operating approaches as it would be designed into the 
process line, and the effects of a criticality event would be minimal and should be contained within 
the hot cell.
5. The potential for a release at the site boundary is reduced due to the additional hard wall 
containment boundary.
6. Overall fuel fabrication time will be minimized by automated material handling between process 
operations.  Fabrication timing would be equivalent to the automated glovebox line approach as 
manipulators are not required to move material between processes.
Disadvantages
1. Automated hot cell fabrication represents the most expensive and longest lead time approach.  It 
would have minimal flexibility.
2. Process setup and testing would need to be done after facility construction.
3. Some maintenance operations may still require cell entry with corresponding radiation exposure 
and potential for worker contamination.
Other Considerations Involved
A fabrication demonstration designed to manufacture sufficient fuel for a lead test assembly in 
three months with the relatively small batch sizes dictated by criticality will be a relatively high speed 
manufacturing operation.  The following logistics issues of managing a large number of small fabrication 
batches (138 for a lead test assembly) will require significant pre-planning and may dictate some level of 
automation:
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1. Batch movement between processes will involve containers compatible with material form, 
criticality concerns, and transfer ports.
2. Storage queues for unit processes that take different process times will need to be strategically 
placed to allow material flow without criticality issues.
3. QC test sequences will need to be integrated with manufacturing to prevent the need for large in-
process storage areas.
4. QA hold points will need to be managed such that needed verifications occur in real time and 
batches are not stacked up waiting on approvals to proceed.
5. A well planned management approach for non-conforming materials will be needed that provides a 
pre-defined, critically-safe storage location for such materials and dictates the time they can spend 
in such storage before a usage decision is required.
6. Process waste stream management must be planned in detail with satellite collection sites and 
procedural sequences for treatment or removal from the facility.
14
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Appendix A
MOX–1 Fuel Dose Rate Calculations
MicroShield v6.10 (6.10-0063)
INL
Page 1
DOS File Gen IV Composition 1.ms6
Run Date August 3, 2005
Run Time 8:57:30 AM
Duration 00:00:18
File Ref
Date
By
Checked
Case Title: Composition #1
Description: 1 kg of of Composition #1 in a compact cube
Geometry: 13 - Rectangular Volume
Source Dimensions:
Length 4.12 cm (1.6 in)
Width 4.12 cm (1.6 in)
Height 4.12 cm (1.6 in)
Dose Points 
A X Y Z
# 1 5.12 cm 2.134 cm 2.134 cm
2.0 in 0.8 in 0.8 in
Shields
Shield N Dimension Material Density
Source 69.935 cm³ Uranium 14.3
Air Gap Air 0.00122
Source Input : Grouping Method - Standard Indices
Number of Groups : 25
Lower Energy Cutoff : 0.015
Photons < 0.015 : Included
Library : Grove
Nuclide curies becquerels µCi/cm³ Bq/cm³
Np-237 2.8100e-003 1.0397e+008 4.0180e+001 1.4867e+006
Np-238 4.8800e-004 1.8056e+007 6.9780e+000 2.5818e+005
Np-239 2.0800e-001 7.6960e+009 2.9742e+003 1.1005e+008
Pu-236 2.2400e-003 8.2880e+007 3.2030e+001 1.1851e+006
Pu-238 3.8300e+001 1.4171e+012 5.4766e+005 2.0263e+010
Pu-239 1.6700e+000 6.1790e+010 2.3879e+004 8.8354e+008
Pu-240 3.5600e+000 1.3172e+011 5.0905e+004 1.8835e+009
Pu-241 4.9500e+002 1.8315e+013 7.0780e+006 2.6189e+011
Pu-242 1.3100e-002 4.8470e+008 1.8732e+002 6.9308e+006
U-232 1.1300e-004 4.1810e+006 1.6158e+000 5.9784e+004
U-233 4.0000e-007 1.4800e+004 5.7196e-003 2.1163e+002
U-234 3.1000e-003 1.1470e+008 4.4327e+001 1.6401e+006
U-235 8.0400e-006 2.9748e+005 1.1496e-001 4.2537e+003
U-236 3.5100e-004 1.2987e+007 5.0190e+000 1.8570e+005
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U-237 3.4600e-003 1.2802e+008 4.9475e+001 1.8306e+006
U-238 3.1400e-004 1.1618e+007 4.4899e+000 1.6613e+005
U-240 3.3700e-009 1.2469e+002 4.8188e-005 1.7830e+000
Buildup : The material reference is - Source
Integration Parameters
X Direction 23
Y Direction 23
Z Direction 23
Sensitivity Analysis Summary - X Dose Point 1
Dose
Point# Sensitivity
Sensitivity
Dimension
Fluence Rate
MeV/cm²/sec
No Buildup
Fluence Rate
MeV/cm²/sec
With Buildup
Exposure Rate
mR/hr
No Buildup
Exposure Rate
mR/hr
With Buildup
1 (1 of 11) (14.12 cm) 1.929e+04 2.187e+04 3.466e+01 3.938e+01
1 (2 of 11) (24.12 cm) 5.034e+03 5.718e+03 9.048e+00 1.030e+01
1 (3 of 11) (34.12 cm) 2.259e+03 2.568e+03 4.060e+00 4.627e+00
1 (4 of 11) (44.12 cm) 1.275e+03 1.450e+03 2.292e+00 2.613e+00
1 (5 of 11) (54.12 cm) 8.168e+02 9.295e+02 1.469e+00 1.675e+00
1 (6 of 11) (64.12 cm) 5.673e+02 6.459e+02 1.020e+00 1.164e+00
1 (7 of 11) (74.12 cm) 4.167e+02 4.745e+02 7.493e-01 8.551e-01
1 (8 of 11) (84.12 cm) 3.188e+02 3.632e+02 5.733e-01 6.545e-01
1 (9 of 11) (94.12 cm) 2.517e+02 2.868e+02 4.526e-01 5.169e-01
1 (10 of 11) (104.12 cm) 2.037e+02 2.321e+02 3.663e-01 4.184e-01
1 (11 of 11) (114.12 cm) 1.682e+02 1.917e+02 3.024e-01 3.455e-01
Results
Energy
MeV
Activity
Photons/sec
Fluence Rate
MeV/cm²/sec
No Buildup
Fluence Rate
MeV/cm²/sec
With Buildup
Exposure Rate
mR/hr
No Buildup
Exposure Rate
mR/hr
With Buildup
0.03 1.760e+07 3.248e-02 3.281e-02 3.219e-04 3.252e-04
0.04 1.848e+04 2.152e-03 2.187e-03 9.518e-06 9.672e-06
0.05 7.736e+07 6.150e+01 6.289e+01 1.638e-01 1.675e-01
0.06 8.016e+08 1.854e+03 1.903e+03 3.683e+00 3.780e+00
0.08 1.328e+07 1.026e+02 1.064e+02 1.623e-01 1.683e-01
0.1 5.663e+09 9.765e+04 1.023e+05 1.494e+02 1.566e+02
0.15 3.448e+07 6.199e+02 1.069e+03 1.021e+00 1.761e+00
0.2 1.138e+09 5.474e+04 6.874e+04 9.661e+01 1.213e+02
0.3 1.434e+09 2.557e+05 2.880e+05 4.850e+02 5.464e+02
0.4 1.440e+05 5.912e+01 6.678e+01 1.152e-01 1.301e-01
0.5 9.832e+04 7.184e+01 8.261e+01 1.410e-01 1.622e-01
0.6 1.848e+04 2.063e+01 2.403e+01 4.027e-02 4.691e-02
0.8 1.371e+05 2.764e+02 3.306e+02 5.256e-01 6.288e-01
1.0 9.709e+06 2.937e+04 3.557e+04 5.414e+01 6.557e+01
Totals 9.189e+09 4.405e+05 4.983e+05 7.910e+02 8.967e+02
Sensitivity Variable X Dose Point 1 (1 of 11) (14.12 cm)
0.03 1.760e+07 5.474e-03 5.529e-03 5.425e-05 5.479e-05
0.04 1.848e+04 2.022e-04 2.052e-04 8.943e-07 9.076e-07
0.05 7.736e+07 3.897e+00 3.976e+00 1.038e-02 1.059e-02
0.06 8.016e+08 9.299e+01 9.511e+01 1.847e-01 1.889e-01
0.08 1.328e+07 4.473e+00 4.626e+00 7.079e-03 7.320e-03
0.1 5.663e+09 4.221e+03 4.418e+03 6.458e+00 6.759e+00
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Results
Energy
MeV
Activity
Photons/sec
Fluence Rate
MeV/cm²/sec
No Buildup
Fluence Rate
MeV/cm²/sec
With Buildup
Exposure Rate
mR/hr
No Buildup
Exposure Rate
mR/hr
With Buildup
0.15 3.448e+07 2.687e+01 4.579e+01 4.425e-02 7.541e-02
0.2 1.138e+09 2.369e+03 2.974e+03 4.180e+00 5.248e+00
0.3 1.434e+09 1.113e+04 1.255e+04 2.112e+01 2.380e+01
0.4 1.440e+05 2.603e+00 2.948e+00 5.073e-03 5.744e-03
0.5 9.832e+04 3.212e+00 3.712e+00 6.305e-03 7.287e-03
0.6 1.848e+04 9.386e-01 1.103e+00 1.832e-03 2.153e-03
0.8 1.371e+05 1.300e+01 1.582e+01 2.472e-02 3.009e-02
1.0 9.709e+06 1.420e+03 1.762e+03 2.618e+00 3.247e+00
Totals 9.189e+09 1.929e+04 2.187e+04 3.466e+01 3.938e+01
Sensitivity Variable X Dose Point 1 (2 of 11) (24.12 cm)
0.03 1.760e+07 1.482e-03 1.497e-03 1.469e-05 1.484e-05
0.04 1.848e+04 5.307e-05 5.385e-05 2.347e-07 2.382e-07
0.05 7.736e+07 1.010e+00 1.030e+00 2.690e-03 2.745e-03
0.06 8.016e+08 2.399e+01 2.453e+01 4.764e-02 4.873e-02
0.08 1.328e+07 1.153e+00 1.193e+00 1.825e-03 1.888e-03
0.1 5.663e+09 1.090e+03 1.141e+03 1.668e+00 1.746e+00
0.15 3.448e+07 6.934e+00 1.184e+01 1.142e-02 1.950e-02
0.2 1.138e+09 6.128e+02 7.701e+02 1.082e+00 1.359e+00
0.3 1.434e+09 2.902e+03 3.273e+03 5.504e+00 6.209e+00
0.4 1.440e+05 6.849e-01 7.769e-01 1.334e-03 1.514e-03
0.5 9.832e+04 8.530e-01 9.887e-01 1.674e-03 1.941e-03
0.6 1.848e+04 2.514e-01 2.968e-01 4.908e-04 5.794e-04
0.8 1.371e+05 3.533e+00 4.332e+00 6.721e-03 8.239e-03
1.0 9.709e+06 3.904e+02 4.888e+02 7.196e-01 9.010e-01
Totals 9.189e+09 5.034e+03 5.718e+03 9.048e+00 1.030e+01
Sensitivity Variable X Dose Point 1 (3 of 11) (34.12 cm)
0.03 1.760e+07 6.668e-04 6.735e-04 6.608e-06 6.675e-06
0.04 1.848e+04 2.375e-05 2.410e-05 1.051e-07 1.066e-07
0.05 7.736e+07 4.511e-01 4.603e-01 1.202e-03 1.226e-03
0.06 8.016e+08 1.071e+01 1.095e+01 2.127e-02 2.175e-02
0.08 1.328e+07 5.150e-01 5.326e-01 8.150e-04 8.429e-04
0.1 5.663e+09 4.872e+02 5.100e+02 7.453e-01 7.803e-01
0.15 3.448e+07 3.098e+00 5.295e+00 5.101e-03 8.720e-03
0.2 1.138e+09 2.740e+02 3.445e+02 4.837e-01 6.081e-01
0.3 1.434e+09 1.301e+03 1.469e+03 2.469e+00 2.786e+00
0.4 1.440e+05 3.082e-01 3.499e-01 6.006e-04 6.818e-04
0.5 9.832e+04 3.853e-01 4.472e-01 7.563e-04 8.777e-04
0.6 1.848e+04 1.140e-01 1.348e-01 2.225e-04 2.631e-04
0.8 1.371e+05 1.611e+00 1.981e+00 3.065e-03 3.768e-03
1.0 9.709e+06 1.788e+02 2.247e+02 3.296e-01 4.143e-01
Totals 9.189e+09 2.259e+03 2.568e+03 4.060e+00 4.627e+00
Sensitivity Variable X Dose Point 1 (4 of 11) (44.12 cm)
0.03 1.760e+07 3.757e-04 3.795e-04 3.724e-06 3.761e-06
0.04 1.848e+04 1.337e-05 1.357e-05 5.913e-08 6.001e-08
0.05 7.736e+07 2.538e-01 2.590e-01 6.762e-04 6.900e-04
0.06 8.016e+08 6.024e+00 6.161e+00 1.196e-02 1.224e-02
0.08 1.328e+07 2.898e-01 2.998e-01 4.587e-04 4.744e-04
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Results
Energy
MeV
Activity
Photons/sec
Fluence Rate
MeV/cm²/sec
No Buildup
Fluence Rate
MeV/cm²/sec
With Buildup
Exposure Rate
mR/hr
No Buildup
Exposure Rate
mR/hr
With Buildup
0.1 5.663e+09 2.743e+02 2.872e+02 4.196e-01 4.393e-01
0.15 3.448e+07 1.744e+00 2.984e+00 2.872e-03 4.914e-03
0.2 1.138e+09 1.544e+02 1.942e+02 2.725e-01 3.427e-01
0.3 1.434e+09 7.343e+02 8.289e+02 1.393e+00 1.572e+00
0.4 1.440e+05 1.743e-01 1.979e-01 3.395e-04 3.856e-04
0.5 9.832e+04 2.182e-01 2.535e-01 4.284e-04 4.975e-04
0.6 1.848e+04 6.467e-02 7.657e-02 1.262e-04 1.494e-04
0.8 1.371e+05 9.172e-01 1.130e+00 1.745e-03 2.149e-03
1.0 9.709e+06 1.020e+02 1.285e+02 1.881e-01 2.369e-01
Totals 9.189e+09 1.275e+03 1.450e+03 2.292e+00 2.613e+00
Sensitivity Variable X Dose Point 1 (5 of 11) (54.12 cm)
0.03 1.760e+07 2.402e-04 2.426e-04 2.380e-06 2.404e-06
0.04 1.848e+04 8.547e-06 8.674e-06 3.780e-08 3.836e-08
0.05 7.736e+07 1.623e-01 1.656e-01 4.323e-04 4.411e-04
0.06 8.016e+08 3.851e+00 3.939e+00 7.649e-03 7.823e-03
0.08 1.328e+07 1.854e-01 1.917e-01 2.933e-04 3.034e-04
0.1 5.663e+09 1.755e+02 1.837e+02 2.684e-01 2.811e-01
0.15 3.448e+07 1.116e+00 1.911e+00 1.837e-03 3.146e-03
0.2 1.138e+09 9.881e+01 1.243e+02 1.744e-01 2.194e-01
0.3 1.434e+09 4.705e+02 5.312e+02 8.924e-01 1.008e+00
0.4 1.440e+05 1.118e-01 1.270e-01 2.178e-04 2.474e-04
0.5 9.832e+04 1.402e-01 1.629e-01 2.751e-04 3.197e-04
0.6 1.848e+04 4.159e-02 4.927e-02 8.117e-05 9.616e-05
0.8 1.371e+05 5.910e-01 7.287e-01 1.124e-03 1.386e-03
1.0 9.709e+06 6.585e+01 8.306e+01 1.214e-01 1.531e-01
Totals 9.189e+09 8.168e+02 9.295e+02 1.469e+00 1.675e+00
Sensitivity Variable X Dose Point 1 (6 of 11) (64.12 cm)
0.03 1.760e+07 1.664e-04 1.680e-04 1.649e-06 1.665e-06
0.04 1.848e+04 5.924e-06 6.012e-06 2.620e-08 2.659e-08
0.05 7.736e+07 1.125e-01 1.148e-01 2.997e-04 3.058e-04
0.06 8.016e+08 2.670e+00 2.731e+00 5.304e-03 5.425e-03
0.08 1.328e+07 1.286e-01 1.330e-01 2.034e-04 2.104e-04
0.1 5.663e+09 1.217e+02 1.275e+02 1.862e-01 1.950e-01
0.15 3.448e+07 7.741e-01 1.327e+00 1.275e-03 2.185e-03
0.2 1.138e+09 6.857e+01 8.631e+01 1.210e-01 1.523e-01
0.3 1.434e+09 3.268e+02 3.690e+02 6.198e-01 7.000e-01
0.4 1.440e+05 7.770e-02 8.829e-02 1.514e-04 1.720e-04
0.5 9.832e+04 9.752e-02 1.134e-01 1.914e-04 2.225e-04
0.6 1.848e+04 2.896e-02 3.432e-02 5.652e-05 6.700e-05
0.8 1.371e+05 4.121e-01 5.085e-01 7.838e-04 9.672e-04
1.0 9.709e+06 4.597e+01 5.804e+01 8.473e-02 1.070e-01
Totals 9.189e+09 5.673e+02 6.459e+02 1.020e+00 1.164e+00
Sensitivity Variable X Dose Point 1 (7 of 11) (74.12 cm)
0.03 1.760e+07 1.219e-04 1.231e-04 1.208e-06 1.220e-06
0.04 1.848e+04 4.343e-06 4.407e-06 1.921e-08 1.949e-08
0.05 7.736e+07 8.249e-02 8.417e-02 2.197e-04 2.242e-04
0.06 8.016e+08 1.958e+00 2.003e+00 3.889e-03 3.978e-03
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Results
Energy
MeV
Activity
Photons/sec
Fluence Rate
MeV/cm²/sec
No Buildup
Fluence Rate
MeV/cm²/sec
With Buildup
Exposure Rate
mR/hr
No Buildup
Exposure Rate
mR/hr
With Buildup
0.08 1.328e+07 9.430e-02 9.755e-02 1.492e-04 1.544e-04
0.1 5.663e+09 8.930e+01 9.353e+01 1.366e-01 1.431e-01
0.15 3.448e+07 5.680e-01 9.744e-01 9.354e-04 1.605e-03
0.2 1.138e+09 5.034e+01 6.338e+01 8.884e-02 1.119e-01
0.3 1.434e+09 2.400e+02 2.711e+02 4.553e-01 5.142e-01
0.4 1.440e+05 5.711e-02 6.490e-02 1.113e-04 1.265e-04
0.5 9.832e+04 7.172e-02 8.339e-02 1.408e-04 1.637e-04
0.6 1.848e+04 2.131e-02 2.527e-02 4.159e-05 4.932e-05
0.8 1.371e+05 3.036e-01 3.748e-01 5.774e-04 7.130e-04
1.0 9.709e+06 3.389e+01 4.282e+01 6.247e-02 7.894e-02
Totals 9.189e+09 4.167e+02 4.745e+02 7.493e-01 8.551e-01
Sensitivity Variable X Dose Point 1 (8 of 11) (84.12 cm)
0.03 1.760e+07 9.298e-05 9.392e-05 9.215e-07 9.308e-07
0.04 1.848e+04 3.317e-06 3.366e-06 1.467e-08 1.489e-08
0.05 7.736e+07 6.302e-02 6.431e-02 1.679e-04 1.713e-04
0.06 8.016e+08 1.496e+00 1.531e+00 2.972e-03 3.040e-03
0.08 1.328e+07 7.208e-02 7.457e-02 1.141e-04 1.180e-04
0.1 5.663e+09 6.827e+01 7.151e+01 1.044e-01 1.094e-01
0.15 3.448e+07 4.343e-01 7.456e-01 7.152e-04 1.228e-03
0.2 1.138e+09 3.850e+01 4.849e+01 6.794e-02 8.558e-02
0.3 1.434e+09 1.836e+02 2.075e+02 3.483e-01 3.935e-01
0.4 1.440e+05 4.372e-02 4.970e-02 8.518e-05 9.683e-05
0.5 9.832e+04 5.494e-02 6.389e-02 1.078e-04 1.254e-04
0.6 1.848e+04 1.633e-02 1.937e-02 3.188e-05 3.781e-05
0.8 1.371e+05 2.328e-01 2.876e-01 4.429e-04 5.471e-04
1.0 9.709e+06 2.601e+01 3.289e+01 4.794e-02 6.062e-02
Totals 9.189e+09 3.188e+02 3.632e+02 5.733e-01 6.545e-01
Sensitivity Variable X Dose Point 1 (9 of 11) (94.12 cm)
0.03 1.760e+07 7.321e-05 7.394e-05 7.255e-07 7.328e-07
0.04 1.848e+04 2.614e-06 2.653e-06 1.156e-08 1.173e-08
0.05 7.736e+07 4.969e-02 5.070e-02 1.324e-04 1.351e-04
0.06 8.016e+08 1.180e+00 1.207e+00 2.344e-03 2.397e-03
0.08 1.328e+07 5.685e-02 5.882e-02 8.996e-05 9.308e-05
0.1 5.663e+09 5.386e+01 5.641e+01 8.240e-02 8.631e-02
0.15 3.448e+07 3.427e-01 5.887e-01 5.643e-04 9.695e-04
0.2 1.138e+09 3.038e+01 3.828e+01 5.362e-02 6.756e-02
0.3 1.434e+09 1.450e+02 1.638e+02 2.750e-01 3.108e-01
0.4 1.440e+05 3.453e-02 3.926e-02 6.728e-05 7.650e-05
0.5 9.832e+04 4.341e-02 5.050e-02 8.521e-05 9.913e-05
0.6 1.848e+04 1.291e-02 1.532e-02 2.520e-05 2.990e-05
0.8 1.371e+05 1.842e-01 2.276e-01 3.503e-04 4.330e-04
1.0 9.709e+06 2.059e+01 2.604e+01 3.795e-02 4.800e-02
Totals 9.189e+09 2.517e+02 2.868e+02 4.526e-01 5.169e-01
Sensitivity Variable X Dose Point 1 (10 of 11) (104.12 cm)
0.03 1.760e+07 5.908e-05 5.968e-05 5.855e-07 5.914e-07
0.04 1.848e+04 2.112e-06 2.143e-06 9.340e-09 9.479e-09
0.05 7.736e+07 4.016e-02 4.098e-02 1.070e-04 1.092e-04
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Results
Energy
MeV
Activity
Photons/sec
Fluence Rate
MeV/cm²/sec
No Buildup
Fluence Rate
MeV/cm²/sec
With Buildup
Exposure Rate
mR/hr
No Buildup
Exposure Rate
mR/hr
With Buildup
0.06 8.016e+08 9.538e-01 9.757e-01 1.894e-03 1.938e-03
0.08 1.328e+07 4.596e-02 4.756e-02 7.274e-05 7.526e-05
0.1 5.663e+09 4.355e+01 4.562e+01 6.663e-02 6.980e-02
0.15 3.448e+07 2.772e-01 4.765e-01 4.564e-04 7.847e-04
0.2 1.138e+09 2.458e+01 3.098e+01 4.338e-02 5.467e-02
0.3 1.434e+09 1.173e+02 1.326e+02 2.226e-01 2.515e-01
0.4 1.440e+05 2.796e-02 3.179e-02 5.447e-05 6.195e-05
0.5 9.832e+04 3.516e-02 4.091e-02 6.901e-05 8.030e-05
0.6 1.848e+04 1.046e-02 1.241e-02 2.041e-05 2.423e-05
0.8 1.371e+05 1.493e-01 1.846e-01 2.840e-04 3.511e-04
1.0 9.709e+06 1.669e+01 2.113e+01 3.077e-02 3.895e-02
Totals 9.189e+09 2.037e+02 2.321e+02 3.663e-01 4.184e-01
Sensitivity Variable X Dose Point 1 (11 of 11) (114.12 cm)
0.03 1.760e+07 4.865e-05 4.913e-05 4.821e-07 4.870e-07
0.04 1.848e+04 1.741e-06 1.766e-06 7.698e-09 7.813e-09
0.05 7.736e+07 3.311e-02 3.379e-02 8.821e-05 9.001e-05
0.06 8.016e+08 7.866e-01 8.047e-01 1.562e-03 1.598e-03
0.08 1.328e+07 3.792e-02 3.924e-02 6.000e-05 6.209e-05
0.1 5.663e+09 3.593e+01 3.765e+01 5.497e-02 5.759e-02
0.15 3.448e+07 2.287e-01 3.935e-01 3.766e-04 6.481e-04
0.2 1.138e+09 2.028e+01 2.557e+01 3.580e-02 4.514e-02
0.3 1.434e+09 9.688e+01 1.095e+02 1.838e-01 2.077e-01
0.4 1.440e+05 2.309e-02 2.626e-02 4.499e-05 5.117e-05
0.5 9.832e+04 2.905e-02 3.381e-02 5.702e-05 6.636e-05
0.6 1.848e+04 8.644e-03 1.026e-02 1.687e-05 2.003e-05
0.8 1.371e+05 1.235e-01 1.527e-01 2.348e-04 2.904e-04
1.0 9.709e+06 1.381e+01 1.748e+01 2.545e-02 3.223e-02
Totals 9.189e+09 1.682e+02 1.917e+02 3.024e-01 3.455e-01
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Appendix B
MOX – 2 Dose Rate Calculations
MicroShield v6.10 (6.10-0063)
INL
Page 1
DOS File Gen IV Composition 2.ms6
Run Date August 3, 2005
Run Time 8:59:36 AM
Duration 00:00:18
File Ref
Date
By
Checked
Case Title: Composition #2
Description: 1 kg of of Composition #2 in a compact cube
Geometry: 13 - Rectangular Volume
Source Dimensions:
Length 4.12 cm (1.6 in)
Width 4.12 cm (1.6 in)
Height 4.12 cm (1.6 in)
Dose Points 
A X Y Z
# 1 5.12 cm 2.134 cm 2.134 cm
2.0 in 0.8 in 0.8 in
Shields
Shield N Dimension Material Density
Source 69.935 cm³ Uranium 14.28
Air Gap Air 0.00122
Source Input : Grouping Method - Standard Indices
Number of Groups : 25
Lower Energy Cutoff : 0.015
Photons < 0.015 : Included
Library : Grove
Nuclide curies becquerels µCi/cm³ Bq/cm³
Am-241 1.9600e+001 7.2520e+011 2.8026e+005 1.0370e+010
Am-242m 1.2000e-001 4.4400e+009 1.7159e+003 6.3488e+007
Am-243 2.5500e-001 9.4350e+009 3.6463e+003 1.3491e+008
Cm-242 3.0400e-001 1.1248e+010 4.3469e+003 1.6084e+008
Cm-243 3.2700e-001 1.2099e+010 4.6758e+003 1.7300e+008
Cm-244 7.3800e+001 2.7306e+012 1.0553e+006 3.9045e+010
Cm-245 1.1500e-002 4.2550e+008 1.6444e+002 6.0843e+006
Cm-246 4.6500e-003 1.7205e+008 6.6491e+001 2.4602e+006
Np-237 2.8100e-003 1.0397e+008 4.0180e+001 1.4867e+006
Np-238 4.8800e-004 1.8056e+007 6.9780e+000 2.5818e+005
Np-239 2.0800e-001 7.6960e+009 2.9742e+003 1.1005e+008
Pu-236 2.2400e-003 8.2880e+007 3.2030e+001 1.1851e+006
Pu-238 3.8300e+001 1.4171e+012 5.4766e+005 2.0263e+010
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Source Input : Grouping Method - Standard Indices
Number of Groups : 25
Lower Energy Cutoff : 0.015
Photons < 0.015 : Included
Library : Grove
Nuclide curies becquerels µCi/cm³ Bq/cm³
Pu-239 1.6700e+000 6.1790e+010 2.3879e+004 8.8354e+008
Pu-240 3.5600e+000 1.3172e+011 5.0905e+004 1.8835e+009
Pu-241 4.9500e+002 1.8315e+013 7.0780e+006 2.6189e+011
Pu-242 1.3100e-002 4.8470e+008 1.8732e+002 6.9308e+006
U-232 1.1200e-004 4.1440e+006 1.6015e+000 5.9255e+004
U-233 3.9700e-007 1.4689e+004 5.6767e-003 2.1004e+002
U-234 3.0700e-003 1.1359e+008 4.3898e+001 1.6242e+006
U-235 7.9700e-006 2.9489e+005 1.1396e-001 4.2167e+003
U-236 3.4800e-004 1.2876e+007 4.9761e+000 1.8412e+005
U-237 3.4300e-003 1.2691e+008 4.9046e+001 1.8147e+006
U-238 3.1100e-004 1.1507e+007 4.4470e+000 1.6454e+005
U-240 3.3400e-009 1.2358e+002 4.7759e-005 1.7671e+000
Buildup : The material reference is - Source
Integration Parameters
X Direction 23
Y Direction 23
Z Direction 23
Sensitivity Analysis Summary - X Dose Point 1
Dose
Point# Sensitivity
Sensitivity
Dimension
Fluence Rate
MeV/cm²/sec
No Buildup
Fluence Rate
MeV/cm²/sec
With Buildup
Exposure Rate
mR/hr
No Buildup
Exposure Rate
mR/hr
With Buildup
1 (1 of 11) (14.12 cm) 7.399e+04 8.028e+04 1.384e+02 1.500e+02
1 (2 of 11) (24.12 cm) 1.919e+04 2.084e+04 3.588e+01 3.892e+01
1 (3 of 11) (34.12 cm) 8.585e+03 9.327e+03 1.606e+01 1.742e+01
1 (4 of 11) (44.12 cm) 4.837e+03 5.257e+03 9.047e+00 9.820e+00
1 (5 of 11) (54.12 cm) 3.096e+03 3.365e+03 5.790e+00 6.287e+00
1 (6 of 11) (64.12 cm) 2.148e+03 2.336e+03 4.018e+00 4.364e+00
1 (7 of 11) (74.12 cm) 1.577e+03 1.715e+03 2.949e+00 3.203e+00
1 (8 of 11) (84.12 cm) 1.206e+03 1.312e+03 2.255e+00 2.450e+00
1 (9 of 11) (94.12 cm) 9.514e+02 1.035e+03 1.779e+00 1.933e+00
1 (10 of 11) (104.12 cm) 7.695e+02 8.373e+02 1.439e+00 1.564e+00
1 (11 of 11) (114.12 cm) 6.350e+02 6.910e+02 1.187e+00 1.291e+00
Results
Energy
MeV
Activity
Photons/sec
Fluence Rate
MeV/cm²/sec
No Buildup
Fluence Rate
MeV/cm²/sec
With Buildup
Exposure Rate
mR/hr
No Buildup
Exposure Rate
mR/hr
With Buildup
0.03 1.819e+10 3.389e+01 3.424e+01 3.359e-01 3.394e-01
0.04 5.381e+08 6.299e+01 6.401e+01 2.786e-01 2.831e-01
0.05 1.015e+08 8.098e+01 8.281e+01 2.157e-01 2.206e-01
0.06 2.633e+11 6.103e+05 6.263e+05 1.212e+03 1.244e+03
0.08 6.272e+09 4.854e+04 5.034e+04 7.681e+01 7.965e+01
0.1 1.176e+10 2.031e+05 2.128e+05 3.107e+02 3.256e+02
0.15 1.406e+08 2.532e+03 4.367e+03 4.170e+00 7.191e+00
0.2 2.815e+09 1.356e+05 1.703e+05 2.394e+02 3.006e+02
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Results
Energy
MeV
Activity
Photons/sec
Fluence Rate
MeV/cm²/sec
No Buildup
Fluence Rate
MeV/cm²/sec
With Buildup
Exposure Rate
mR/hr
No Buildup
Exposure Rate
mR/hr
With Buildup
0.3 3.225e+09 5.757e+05 6.486e+05 1.092e+03 1.230e+03
0.4 1.427e+05 5.868e+01 6.629e+01 1.143e-01 1.292e-01
0.5 9.832e+04 7.193e+01 8.271e+01 1.412e-01 1.624e-01
0.6 1.848e+04 2.065e+01 2.406e+01 4.032e-02 4.697e-02
0.8 1.371e+05 2.767e+02 3.309e+02 5.262e-01 6.295e-01
1.0 9.709e+06 2.940e+04 3.560e+04 5.420e+01 6.563e+01
Totals 3.063e+11 1.606e+06 1.749e+06 2.991e+03 3.255e+03
Sensitivity Variable X Dose Point 1 (1 of 11) (14.12 cm)
0.03 1.819e+10 5.706e+00 5.764e+00 5.655e-02 5.712e-02
0.04 5.381e+08 5.912e+00 6.000e+00 2.615e-02 2.654e-02
0.05 1.015e+08 5.127e+00 5.231e+00 1.366e-02 1.394e-02
0.06 2.633e+11 3.059e+04 3.129e+04 6.076e+01 6.214e+01
0.08 6.272e+09 2.117e+03 2.189e+03 3.349e+00 3.463e+00
0.1 1.176e+10 8.781e+03 9.190e+03 1.343e+01 1.406e+01
0.15 1.406e+08 1.098e+02 1.870e+02 1.807e-01 3.080e-01
0.2 2.815e+09 5.869e+03 7.369e+03 1.036e+01 1.301e+01
0.3 3.225e+09 2.507e+04 2.825e+04 4.755e+01 5.359e+01
0.4 1.427e+05 2.584e+00 2.926e+00 5.035e-03 5.702e-03
0.5 9.832e+04 3.217e+00 3.717e+00 6.314e-03 7.296e-03
0.6 1.848e+04 9.398e-01 1.105e+00 1.834e-03 2.156e-03
0.8 1.371e+05 1.301e+01 1.584e+01 2.475e-02 3.012e-02
1.0 9.709e+06 1.422e+03 1.764e+03 2.621e+00 3.251e+00
Totals 3.063e+11 7.399e+04 8.028e+04 1.384e+02 1.500e+02
Sensitivity Variable X Dose Point 1 (2 of 11) (24.12 cm)
0.03 1.819e+10 1.545e+00 1.560e+00 1.531e-02 1.547e-02
0.04 5.381e+08 1.551e+00 1.574e+00 6.862e-03 6.963e-03
0.05 1.015e+08 1.329e+00 1.356e+00 3.540e-03 3.612e-03
0.06 2.633e+11 7.890e+03 8.069e+03 1.567e+01 1.603e+01
0.08 6.272e+09 5.458e+02 5.643e+02 8.636e-01 8.930e-01
0.1 1.176e+10 2.268e+03 2.374e+03 3.470e+00 3.632e+00
0.15 1.406e+08 2.832e+01 4.836e+01 4.664e-02 7.963e-02
0.2 2.815e+09 1.519e+03 1.908e+03 2.680e+00 3.368e+00
0.3 3.225e+09 6.535e+03 7.371e+03 1.240e+01 1.398e+01
0.4 1.427e+05 6.799e-01 7.712e-01 1.325e-03 1.503e-03
0.5 9.832e+04 8.541e-01 9.900e-01 1.677e-03 1.943e-03
0.6 1.848e+04 2.518e-01 2.972e-01 4.914e-04 5.801e-04
0.8 1.371e+05 3.538e+00 4.337e+00 6.729e-03 8.250e-03
1.0 9.709e+06 3.909e+02 4.894e+02 7.205e-01 9.021e-01
Totals 3.063e+11 1.919e+04 2.084e+04 3.588e+01 3.892e+01
Sensitivity Variable X Dose Point 1 (3 of 11) (34.12 cm)
0.03 1.819e+10 6.951e-01 7.020e-01 6.888e-03 6.958e-03
0.04 5.381e+08 6.945e-01 7.047e-01 3.071e-03 3.117e-03
0.05 1.015e+08 5.935e-01 6.056e-01 1.581e-03 1.613e-03
0.06 2.633e+11 3.522e+03 3.602e+03 6.995e+00 7.154e+00
0.08 6.272e+09 2.437e+02 2.520e+02 3.856e-01 3.988e-01
0.1 1.176e+10 1.013e+03 1.061e+03 1.550e+00 1.623e+00
0.15 1.406e+08 1.265e+01 2.163e+01 2.084e-02 3.562e-02
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Results
Energy
MeV
Activity
Photons/sec
Fluence Rate
MeV/cm²/sec
No Buildup
Fluence Rate
MeV/cm²/sec
With Buildup
Exposure Rate
mR/hr
No Buildup
Exposure Rate
mR/hr
With Buildup
0.2 2.815e+09 6.791e+02 8.538e+02 1.199e+00 1.507e+00
0.3 3.225e+09 2.931e+03 3.307e+03 5.559e+00 6.273e+00
0.4 1.427e+05 3.060e-01 3.474e-01 5.962e-04 6.768e-04
0.5 9.832e+04 3.858e-01 4.478e-01 7.574e-04 8.789e-04
0.6 1.848e+04 1.141e-01 1.350e-01 2.228e-04 2.634e-04
0.8 1.371e+05 1.613e+00 1.984e+00 3.069e-03 3.773e-03
1.0 9.709e+06 1.790e+02 2.250e+02 3.300e-01 4.148e-01
Totals 3.063e+11 8.585e+03 9.327e+03 1.606e+01 1.742e+01
Sensitivity Variable X Dose Point 1 (4 of 11) (44.12 cm)
0.03 1.819e+10 3.917e-01 3.956e-01 3.882e-03 3.921e-03
0.04 5.381e+08 3.909e-01 3.967e-01 1.729e-03 1.754e-03
0.05 1.015e+08 3.340e-01 3.407e-01 8.896e-04 9.077e-04
0.06 2.633e+11 1.981e+03 2.026e+03 3.936e+00 4.025e+00
0.08 6.272e+09 1.371e+02 1.418e+02 2.170e-01 2.244e-01
0.1 1.176e+10 5.705e+02 5.973e+02 8.728e-01 9.139e-01
0.15 1.406e+08 7.124e+00 1.219e+01 1.173e-02 2.007e-02
0.2 2.815e+09 3.826e+02 4.812e+02 6.752e-01 8.492e-01
0.3 3.225e+09 1.654e+03 1.867e+03 3.137e+00 3.541e+00
0.4 1.427e+05 1.730e-01 1.964e-01 3.370e-04 3.828e-04
0.5 9.832e+04 2.185e-01 2.538e-01 4.290e-04 4.982e-04
0.6 1.848e+04 6.476e-02 7.667e-02 1.264e-04 1.497e-04
0.8 1.371e+05 9.184e-01 1.131e+00 1.747e-03 2.152e-03
1.0 9.709e+06 1.022e+02 1.287e+02 1.883e-01 2.372e-01
Totals 3.063e+11 4.837e+03 5.257e+03 9.047e+00 9.820e+00
Sensitivity Variable X Dose Point 1 (5 of 11) (54.12 cm)
0.03 1.819e+10 2.503e-01 2.529e-01 2.481e-03 2.506e-03
0.04 5.381e+08 2.499e-01 2.536e-01 1.105e-03 1.122e-03
0.05 1.015e+08 2.135e-01 2.178e-01 5.687e-04 5.803e-04
0.06 2.633e+11 1.267e+03 1.296e+03 2.516e+00 2.573e+00
0.08 6.272e+09 8.770e+01 9.071e+01 1.388e-01 1.435e-01
0.1 1.176e+10 3.650e+02 3.822e+02 5.584e-01 5.847e-01
0.15 1.406e+08 4.557e+00 7.805e+00 7.505e-03 1.285e-02
0.2 2.815e+09 2.448e+02 3.081e+02 4.321e-01 5.437e-01
0.3 3.225e+09 1.059e+03 1.196e+03 2.010e+00 2.269e+00
0.4 1.427e+05 1.110e-01 1.261e-01 2.162e-04 2.456e-04
0.5 9.832e+04 1.404e-01 1.631e-01 2.755e-04 3.201e-04
0.6 1.848e+04 4.164e-02 4.933e-02 8.128e-05 9.629e-05
0.8 1.371e+05 5.918e-01 7.296e-01 1.126e-03 1.388e-03
1.0 9.709e+06 6.593e+01 8.316e+01 1.215e-01 1.533e-01
Totals 3.063e+11 3.096e+03 3.365e+03 5.790e+00 6.287e+00
Sensitivity Variable X Dose Point 1 (6 of 11) (64.12 cm)
0.03 1.819e+10 1.734e-01 1.752e-01 1.719e-03 1.736e-03
0.04 5.381e+08 1.732e-01 1.758e-01 7.661e-04 7.774e-04
0.05 1.015e+08 1.480e-01 1.510e-01 3.943e-04 4.023e-04
0.06 2.633e+11 8.783e+02 8.983e+02 1.745e+00 1.784e+00
0.08 6.272e+09 6.082e+01 6.291e+01 9.625e-02 9.956e-02
0.1 1.176e+10 2.532e+02 2.651e+02 3.873e-01 4.056e-01
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Results
Energy
MeV
Activity
Photons/sec
Fluence Rate
MeV/cm²/sec
No Buildup
Fluence Rate
MeV/cm²/sec
With Buildup
Exposure Rate
mR/hr
No Buildup
Exposure Rate
mR/hr
With Buildup
0.15 1.406e+08 3.162e+00 5.419e+00 5.207e-03 8.924e-03
0.2 2.815e+09 1.699e+02 2.139e+02 2.999e-01 3.775e-01
0.3 3.225e+09 7.359e+02 8.310e+02 1.396e+00 1.576e+00
0.4 1.427e+05 7.713e-02 8.765e-02 1.503e-04 1.708e-04
0.5 9.832e+04 9.766e-02 1.135e-01 1.917e-04 2.228e-04
0.6 1.848e+04 2.900e-02 3.437e-02 5.660e-05 6.709e-05
0.8 1.371e+05 4.127e-01 5.092e-01 7.849e-04 9.685e-04
1.0 9.709e+06 4.603e+01 5.811e+01 8.484e-02 1.071e-01
Totals 3.063e+11 2.148e+03 2.336e+03 4.018e+00 4.364e+00
Sensitivity Variable X Dose Point 1 (7 of 11) (74.12 cm)
0.03 1.819e+10 1.270e-01 1.283e-01 1.259e-03 1.272e-03
0.04 5.381e+08 1.270e-01 1.289e-01 5.615e-04 5.699e-04
0.05 1.015e+08 1.085e-01 1.107e-01 2.891e-04 2.950e-04
0.06 2.633e+11 6.441e+02 6.588e+02 1.279e+00 1.309e+00
0.08 6.272e+09 4.462e+01 4.615e+01 7.061e-02 7.304e-02
0.1 1.176e+10 1.858e+02 1.945e+02 2.842e-01 2.976e-01
0.15 1.406e+08 2.320e+00 3.980e+00 3.821e-03 6.554e-03
0.2 2.815e+09 1.247e+02 1.571e+02 2.201e-01 2.772e-01
0.3 3.225e+09 5.405e+02 6.105e+02 1.025e+00 1.158e+00
0.4 1.427e+05 5.669e-02 6.443e-02 1.105e-04 1.255e-04
0.5 9.832e+04 7.182e-02 8.351e-02 1.410e-04 1.639e-04
0.6 1.848e+04 2.134e-02 2.530e-02 4.165e-05 4.939e-05
0.8 1.371e+05 3.040e-01 3.753e-01 5.782e-04 7.139e-04
1.0 9.709e+06 3.393e+01 4.288e+01 6.255e-02 7.904e-02
Totals 3.063e+11 1.577e+03 1.715e+03 2.949e+00 3.203e+00
Sensitivity Variable X Dose Point 1 (8 of 11) (84.12 cm)
0.03 1.819e+10 9.692e-02 9.790e-02 9.606e-04 9.702e-04
0.04 5.381e+08 9.697e-02 9.841e-02 4.289e-04 4.352e-04
0.05 1.015e+08 8.292e-02 8.460e-02 2.209e-04 2.254e-04
0.06 2.633e+11 4.922e+02 5.035e+02 9.777e-01 1.000e+00
0.08 6.272e+09 3.410e+01 3.528e+01 5.397e-02 5.583e-02
0.1 1.176e+10 1.420e+02 1.487e+02 2.173e-01 2.276e-01
0.15 1.406e+08 1.774e+00 3.046e+00 2.921e-03 5.015e-03
0.2 2.815e+09 9.539e+01 1.202e+02 1.684e-01 2.121e-01
0.3 3.225e+09 4.136e+02 4.672e+02 7.845e-01 8.862e-01
0.4 1.427e+05 4.340e-02 4.934e-02 8.456e-05 9.613e-05
0.5 9.832e+04 5.501e-02 6.398e-02 1.080e-04 1.256e-04
0.6 1.848e+04 1.635e-02 1.940e-02 3.192e-05 3.786e-05
0.8 1.371e+05 2.332e-01 2.880e-01 4.435e-04 5.479e-04
1.0 9.709e+06 2.604e+01 3.293e+01 4.801e-02 6.070e-02
Totals 3.063e+11 1.206e+03 1.312e+03 2.255e+00 2.450e+00
Sensitivity Variable X Dose Point 1 (9 of 11) (94.12 cm)
0.03 1.819e+10 7.631e-02 7.708e-02 7.563e-04 7.639e-04
0.04 5.381e+08 7.642e-02 7.756e-02 3.380e-04 3.430e-04
0.05 1.015e+08 6.537e-02 6.670e-02 1.741e-04 1.777e-04
0.06 2.633e+11 3.881e+02 3.970e+02 7.709e-01 7.886e-01
0.08 6.272e+09 2.690e+01 2.783e+01 4.256e-02 4.404e-02
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Results
Energy
MeV
Activity
Photons/sec
Fluence Rate
MeV/cm²/sec
No Buildup
Fluence Rate
MeV/cm²/sec
With Buildup
Exposure Rate
mR/hr
No Buildup
Exposure Rate
mR/hr
With Buildup
0.1 1.176e+10 1.120e+02 1.173e+02 1.714e-01 1.795e-01
0.15 1.406e+08 1.400e+00 2.405e+00 2.305e-03 3.960e-03
0.2 2.815e+09 7.528e+01 9.485e+01 1.329e-01 1.674e-01
0.3 3.225e+09 3.265e+02 3.689e+02 6.194e-01 6.998e-01
0.4 1.427e+05 3.428e-02 3.898e-02 6.679e-05 7.594e-05
0.5 9.832e+04 4.347e-02 5.057e-02 8.533e-05 9.927e-05
0.6 1.848e+04 1.293e-02 1.534e-02 2.523e-05 2.994e-05
0.8 1.371e+05 1.844e-01 2.279e-01 3.508e-04 4.336e-04
1.0 9.709e+06 2.061e+01 2.608e+01 3.800e-02 4.806e-02
Totals 3.063e+11 9.514e+02 1.035e+03 1.779e+00 1.933e+00
Sensitivity Variable X Dose Point 1 (10 of 11) (104.12 cm)
0.03 1.819e+10 6.159e-02 6.220e-02 6.103e-04 6.165e-04
0.04 5.381e+08 6.174e-02 6.266e-02 2.731e-04 2.771e-04
0.05 1.015e+08 5.283e-02 5.391e-02 1.407e-04 1.436e-04
0.06 2.633e+11 3.137e+02 3.209e+02 6.232e-01 6.374e-01
0.08 6.272e+09 2.175e+01 2.250e+01 3.441e-02 3.561e-02
0.1 1.176e+10 9.059e+01 9.490e+01 1.386e-01 1.452e-01
0.15 1.406e+08 1.132e+00 1.947e+00 1.864e-03 3.205e-03
0.2 2.815e+09 6.090e+01 7.676e+01 1.075e-01 1.355e-01
0.3 3.225e+09 2.642e+02 2.986e+02 5.012e-01 5.665e-01
0.4 1.427e+05 2.775e-02 3.156e-02 5.408e-05 6.149e-05
0.5 9.832e+04 3.521e-02 4.097e-02 6.911e-05 8.041e-05
0.6 1.848e+04 1.047e-02 1.243e-02 2.044e-05 2.426e-05
0.8 1.371e+05 1.495e-01 1.849e-01 2.844e-04 3.516e-04
1.0 9.709e+06 1.672e+01 2.116e+01 3.081e-02 3.900e-02
Totals 3.063e+11 7.695e+02 8.373e+02 1.439e+00 1.564e+00
Sensitivity Variable X Dose Point 1 (11 of 11) (114.12 cm)
0.03 1.819e+10 5.071e-02 5.122e-02 5.025e-04 5.076e-04
0.04 5.381e+08 5.089e-02 5.164e-02 2.251e-04 2.284e-04
0.05 1.015e+08 4.356e-02 4.445e-02 1.160e-04 1.184e-04
0.06 2.633e+11 2.587e+02 2.647e+02 5.139e-01 5.257e-01
0.08 6.272e+09 1.794e+01 1.856e+01 2.839e-02 2.938e-02
0.1 1.176e+10 7.474e+01 7.831e+01 1.143e-01 1.198e-01
0.15 1.406e+08 9.342e-01 1.608e+00 1.538e-03 2.647e-03
0.2 2.815e+09 5.027e+01 6.337e+01 8.872e-02 1.119e-01
0.3 3.225e+09 2.182e+02 2.466e+02 4.138e-01 4.678e-01
0.4 1.427e+05 2.292e-02 2.607e-02 4.466e-05 5.080e-05
0.5 9.832e+04 2.909e-02 3.385e-02 5.709e-05 6.645e-05
0.6 1.848e+04 8.655e-03 1.028e-02 1.689e-05 2.006e-05
0.8 1.371e+05 1.236e-01 1.529e-01 2.351e-04 2.908e-04
1.0 9.709e+06 1.383e+01 1.751e+01 2.549e-02 3.227e-02
Totals 3.063e+11 6.350e+02 6.910e+02 1.187e+00 1.291e+00
